Clinical Scorecard: Assessment of MRI for the Initial Staging of Esophageal Cancer: Insights from the STIRMCO Study
At a Glance
Category
Detail
Condition
Esophageal cancer (EC), including squamous cell carcinoma and adenocarcinoma
Key Mechanisms
Tumor staging using imaging modalities (MRI, CT, PET/CT, EUS) based on UICC-AJCC TNM 8th edition
Target Population
Adults (≥18 years) with newly diagnosed, histologically proven esophageal cancer including gastro-esophageal junction cancers
Care Setting
Initial diagnostic and staging workup in specialized oncology and radiology centers
Key Highlights
MRI offers high contrast resolution, multiplanar imaging, and functional imaging without ionizing radiation.
MRI shows high sensitivity and specificity for T staging (86% and 95%) and moderate sensitivity and specificity for N staging (71% and 72%).
MRI can be performed in stenotic tumors where EUS is limited and is less invasive, not requiring general anesthesia.
Guideline-Based Recommendations
Diagnosis
Use a combination of contrast-enhanced CT, PET/CT, and EUS for initial staging of esophageal cancer.
MRI may be considered as an alternative or complementary modality for locoregional tumor staging, especially when EUS is contraindicated or limited.
Follow the 8th edition UICC-AJCC TNM staging system for tumor extension assessment.
Management
Early-stage EC may be treated with endoscopic resection or surgery alone.
Locally advanced squamous cell carcinoma should receive definitive chemoradiotherapy or neoadjuvant treatment including preoperative chemoradiotherapy or perioperative chemotherapy.
Metastatic EC is managed with palliative chemotherapy with or without immunotherapy.
Monitoring & Follow-up
Imaging modalities should be independently reviewed by experienced readers with consensus in case of discrepancies.
MRI sequences including T2-weighted, diffusion-weighted imaging (DWI), and dynamic contrast-enhanced imaging are recommended for comprehensive staging.
Risks
CT and PET/CT involve ionizing radiation exposure.
EUS may be limited by tumor stenosis and requires general anesthesia.
MRI contraindications include patient factors such as pregnancy and MRI-incompatible implants.
Patient & Prescribing Data
Adults with newly diagnosed esophageal cancer undergoing initial staging
MRI combined with PET/CT provides a radiation-free alternative for locoregional and metastatic staging, potentially improving diagnostic accuracy and patient comfort.
Clinical Best Practices
Perform MRI using a 3-Tesla scanner with comprehensive sequences including T2-weighted, DWI, and dynamic contrast-enhanced imaging.
Use MRI especially in cases where EUS is contraindicated or limited by tumor stenosis.
Ensure multidisciplinary review of imaging results with consensus reading to optimize staging accuracy.
Incorporate MRI findings alongside CT and PET/CT for a holistic assessment of tumor stage and metastasis.
by Vincent Levy, Mario Jreige, Laura Haefliger, Celine Du Pasquier, Camille Noirot, Anna Dorothea Wagner, Styliani Mantziari, Markus Schäfer, Naik Vietti-Violi, Clarisse Dromain
